NFKB1 and neoplasm: In colorectal cancer, RSV co-treatment with 5-FU (IC50 = 1.95 μM for NF-κB [44]) suppresses NF-κB and VEGF pathways, reducing epithelial-mesenchymal transition (EMT) and tumor-initiating cell populations.